Hindustan Bio Sciences (BOM:532041) EV-to-EBIT : 85.97 (As of May. 27, 2024)

View and export this data going back to 1996. Start your Free Trial

What is Hindustan Bio Sciences EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Hindustan Bio Sciences's Enterprise Value is ₹113.48 Mil. Hindustan Bio Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1.32 Mil. Therefore, Hindustan Bio Sciences's EV-to-EBIT for today is 85.97.

The historical rank and industry rank for Hindustan Bio Sciences's EV-to-EBIT or its related term are showing as below:

BOM:532041' s EV-to-EBIT Range Over the Past 10 Years
Min: -236.28 Med: -1.44 Max: 492.01
Current: 85.97

During the past 13 years, the highest EV-to-EBIT of Hindustan Bio Sciences was 492.01. The lowest was -236.28. And the median was -1.44.

BOM:532041's EV-to-EBIT is ranked worse than
93.11% of 668 companies
in the Drug Manufacturers industry
Industry Median: 17.155 vs BOM:532041: 85.97

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Hindustan Bio Sciences's Enterprise Value for the quarter that ended in Dec. 2023 was ₹91.44 Mil. Hindustan Bio Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1.32 Mil. Hindustan Bio Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1.44%.

Hindustan Bio Sciences EV-to-EBIT Historical Data

The historical data trend for Hindustan Bio Sciences's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hindustan Bio Sciences EV-to-EBIT Chart

Hindustan Bio Sciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-EBIT

Get a 7-Day Free Trial

36.47

31.52

-33.11

-14.31

-142.07

Hindustan Bio Sciences Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-13.95	-10.40	-142.07	76.72	69.27

Competitive Comparison of Hindustan Bio Sciences's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hindustan Bio Sciences's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hindustan Bio Sciences's EV-to-EBIT falls into.

Hindustan Bio Sciences EV-to-EBIT Calculation

Hindustan Bio Sciences's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	113.483	/	1.32
	=	85.97

Hindustan Bio Sciences's current Enterprise Value is ₹113.48 Mil.
Hindustan Bio Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.32 Mil.

Hindustan Bio Sciences (BOM:532041) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Hindustan Bio Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	1.32	/	91.437136
	=	1.44 %

Hindustan Bio Sciences's Enterprise Value for the quarter that ended in Dec. 2023 was ₹91.44 Mil.
Hindustan Bio Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.32 Mil.

Hindustan Bio Sciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Hindustan Bio Sciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Hindustan Bio Sciences (BOM:532041) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hindustan Bio Sciences Ltd (BOM:532041) » Definitions » EV-to-EBIT

Traded in Other Exchanges

N/A

Address

Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034

Website

https://www.hindustanbiosciences.in

Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.

Hindustan Bio Sciences (BOM:532041) Headlines

No Headlines